GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (NAS:ANGO) » Definitions » Cyclically Adjusted PB Ratio

AngioDynamics (AngioDynamics) Cyclically Adjusted PB Ratio : 0.37 (As of Apr. 27, 2024)


View and export this data going back to 2004. Start your Free Trial

What is AngioDynamics Cyclically Adjusted PB Ratio?

As of today (2024-04-27), AngioDynamics's current share price is $5.81. AngioDynamics's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2024 was $15.81. AngioDynamics's Cyclically Adjusted PB Ratio for today is 0.37.

The historical rank and industry rank for AngioDynamics's Cyclically Adjusted PB Ratio or its related term are showing as below:

ANGO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.34   Med: 1.04   Max: 1.89
Current: 0.37

During the past years, AngioDynamics's highest Cyclically Adjusted PB Ratio was 1.89. The lowest was 0.34. And the median was 1.04.

ANGO's Cyclically Adjusted PB Ratio is ranked better than
89.91% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 2.11 vs ANGO: 0.37

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

AngioDynamics's adjusted book value per share data for the three months ended in Feb. 2024 was $5.410. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $15.81 for the trailing ten years ended in Feb. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


AngioDynamics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for AngioDynamics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioDynamics Cyclically Adjusted PB Ratio Chart

AngioDynamics Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.13 0.63 1.42 1.17 0.57

AngioDynamics Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.57 0.49 0.40 0.35

Competitive Comparison of AngioDynamics's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, AngioDynamics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AngioDynamics's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AngioDynamics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where AngioDynamics's Cyclically Adjusted PB Ratio falls into.



AngioDynamics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

AngioDynamics's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=5.81/15.81
=0.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AngioDynamics's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2024 is calculated as:

For example, AngioDynamics's adjusted Book Value per Share data for the three months ended in Feb. 2024 was:

Adj_Book=Book Value per Share/CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=5.41/129.4194*129.4194
=5.410

Current CPI (Feb. 2024) = 129.4194.

AngioDynamics Quarterly Data

Book Value per Share CPI Adj_Book
201405 15.208 100.373 19.609
201408 15.201 100.352 19.604
201411 15.262 99.635 19.824
201502 15.154 99.032 19.804
201505 15.183 100.333 19.585
201508 15.142 100.548 19.490
201511 15.152 100.135 19.583
201602 15.204 100.040 19.669
201605 13.982 101.355 17.853
201608 13.955 101.617 17.773
201611 14.337 101.829 18.222
201702 14.457 102.779 18.204
201705 13.980 103.256 17.522
201708 13.986 103.587 17.474
201711 14.045 104.072 17.466
201802 14.481 105.052 17.840
201805 14.576 106.148 17.772
201808 14.534 106.383 17.681
201811 14.653 106.338 17.834
201902 14.742 106.649 17.890
201905 16.345 108.048 19.578
201908 16.164 108.245 19.326
201911 16.155 108.519 19.266
202002 16.038 109.139 19.018
202005 11.946 108.175 14.292
202008 11.874 109.662 14.013
202011 11.853 109.793 13.972
202102 11.814 110.968 13.778
202105 11.399 113.576 12.989
202108 11.172 115.421 12.527
202111 11.062 117.269 12.208
202202 10.976 119.703 11.867
202205 10.837 123.323 11.373
202208 10.488 124.958 10.862
202211 10.327 125.607 10.640
202302 10.040 126.928 10.237
202305 9.550 128.314 9.632
202308 10.637 129.538 10.627
202311 9.975 129.548 9.965
202402 5.410 129.419 5.410

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AngioDynamics  (NAS:ANGO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


AngioDynamics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of AngioDynamics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AngioDynamics (AngioDynamics) Business Description

Traded in Other Exchanges
Address
14 Plaza Drive, Latham, NY, USA, 12110
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.
Executives
Lorinda Burgess director 22 WEST FRONTAG ROAD, NORTHBROOK IL 60093
Karen A Licitra director C/O SI-BONE, INC., 471 EL CAMINO REAL, SUITE 101, SANTA CLARA CA 95050
Michael E Tarnoff director C/O ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Scott Centea officer: SVP/GM, VIT C/O ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Dave Helsel officer: SVP Global Operations and R&D 400 WOOD ROAD, BRAINTREE MA 02184
Laura Piccinini officer: SVP International C/O ANGIODYNAMICS INC., 14 PLAZA DRIVE, LATHAM NY 12110
Stephen A Trowbridge officer: SVP and General Counsel 14 PLAZA DRIVE, LATHAM NY 120110
James C Clemmer director, officer: President and CEO COVIDIEN PLC, 15 HAMPSHIRE STREET, MANSFIELD MA 02048
Wesley Johnson director
Chad Thomas Campbell officer: SVP/GM, Vascular Access 140 POKANOKET PATH, WRENTHAM MA 02093
Warren Jr Nighan officer: SVP Quality and Regulatory ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Richard C Rosenzweig officer: SVP and General Counsel C/O DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Kevin J Gould director 247 WASHINGTON STREET, DUXBURY MA 02332
Brent J. Boucher officer: SVP and GM of Oncology 14 PLAZA DRIVE, LATHAM NY 12110
Michael Greiner officer: EVP and CFO C/O VISTAPRINT, 95 HAYDEN AVENUE, LEXINGTON MA 02421